Diabetes Drug for Cancer
Posted on: Saturday, 23 April 2005, 09:00 CDT
A DRUG commonly used to treat diabetes could help prevent cancer tumours, university researchers claim.
Tests by University of Dundee scientists suggest people with Type 2 diabetes who take metformin may have a reduced risk of developing cancer of more than 25%.
The study was carried out by Professor Dario Alessi, of the university's School of Life Sciences, Professor Andrew Morris, Scotland's leading clinician on diabetes, and Dr Josie Evans, an epidemiologist from the university's Medical School.
The team compared diabetic patients with and without cancer to see how many had been treated with metformin.
The drug 'switches on' the enzyme AMPK which may inhibit cancer cell growth
Source: Daily Post; Liverpool
Related Articles
- Pancreatic Cancer Risk Decreased By One Anti-Diabetic Therapy, Increased By Others
- Breath Or Urine Analysis May Detect Cancer And Diabetes
- Cancer and Diabetes are a Deadly Combo
- FivePrime and Pfizer Collaborate in Cancer and Diabetes Research
- Agennix Receives FDA Fast Track Designation for Talactoferrin Alfa in Non-Small Cell Lung Cancer and Diabetic Foot Ulcers
- Groundbreaking Cancer and Diabetes Therapies, Drug Delivery Modes Highlight Florida Tech Transfer Conference Agenda
- CHOLESTEROL DRUG MAY BE A LOT MORE: Cancer. Alzheimer's. Diabetes. Osteoporosis. These Are Just Some of the Diseases That Researchers Hope Can Be Treated or Prevented With Statins.
- Eightfold Risk of Pancreatic Cancer in Diabetics
- Face to Face With Chronic Disease -- The Personal Impact of the Growing Epidemics of Heart Disease, Stroke, Cancer and Diabetes
- New Tool to Study Elusive DNA Structure Could Help Reveal Better Understanding of Cancer, Diabetes
 |
 |
User Comments (0)
RSS Feeds